Streetbeat News

Products Services

BP

EQNR

SHEL

TTE

TotalEnergies, BP, Shell, and Equinor have announced a $500 million joint investment to enhance access to sustainable modern energy sources.

Portfolio Pulse from

November 15, 2024 | 6:30 am

SDZNY

Sandoz has received European Commission approval for Afqlir® (aflibercept), a biosimilar to Eylea®, to treat retinal diseases. This strengthens Sandoz's biosimilar portfolio and reinforces its leadership in the global and European markets.

Portfolio Pulse from

November 15, 2024 | 6:15 am

REGN

Regeneron Pharmaceuticals and Sanofi announced that the FDA has accepted the resubmission of the sBLA for Dupixent to treat chronic spontaneous urticaria (CSU). If approved, it would be the first targeted therapy for CSU in a decade, with a decision expected by April 18, 2025.

Portfolio Pulse from

November 15, 2024 | 6:15 am

REGN

The FDA has accepted the resubmission of the supplemental biologics license application for Dupixent to treat chronic spontaneous urticaria. This could make Dupixent the first targeted therapy for CSU in a decade, with a decision expected by April 18, 2025.

Portfolio Pulse from

November 15, 2024 | 6:15 am

LLY

Eli Lilly has filed a lawsuit against the Health Resources and Services Administration (HRSA) for allegedly obstructing its plan to modify drug discount offerings to hospitals.

Portfolio Pulse from

November 15, 2024 | 5:30 am

MCHI

The iShares MSCI China ETF (MCHI) is facing mixed impacts from Beijing's economic stimulus and potential tariff threats from Trump's re-election campaign. While China's stimulus has positively influenced MCHI, the anticipation of Trump's re-election and associated tariffs pose a risk. MCHI's performance is significantly tied to domestic consumption, with consumer cyclicals comprising 31% of the ETF.

Portfolio Pulse from

November 15, 2024 | 5:15 am

TIVC

Tivic Health Systems, Inc. (Nasdaq: TIVC) announced its third quarter 2024 financial results and discussed growth strategies focused on its vagus nerve stimulation technology.

Portfolio Pulse from

November 15, 2024 | 5:00 am

INGR

Ingredion and Lantmännen have formed a strategic partnership to enhance their capabilities in the plant-based protein market, which is rapidly growing and evolving.

Portfolio Pulse from

November 15, 2024 | 4:15 am

DIS

Disney is launching its first cruise in Asia, with bookings opening soon. The Disney Adventure cruise starts at $958 for two people, with higher rates for ocean views, verandahs, and 'Frozen' themed suites.

Portfolio Pulse from

November 15, 2024 | 4:00 am